Exploring In-Process Control Strategy for Drug-Linker Synthesis & Conjugation Process Development

  • Leveraging multiple analytical tools to understand and define optimal conjugation process
  • Using analytical tools to understand and define the end of reduction, conjugation, and TFF purification process operations
  • Utilizing purging data of small molecule impurities during development to justify the release/stability specification of final ADC drug substance